Glycogen Synthase: A Catalytic Enzyme in The Metabolism of Glucose

Target Name: Glycogen synthase

NCBI ID: P41734

Glycogen synthase

Other Name(s): Glycogen synthase | GS | GYS

Glycogen Synthase: A Catalytic Enzyme in The Metabolism of Glucose

Glycogen synthase (nonspecified subtype), also known as GSS, is a protein that plays a crucial role in the metabolism of glucose. It is an enzyme that catalyzes the final step of the glycogen biosynthesis pathway, which is the process by which the body stores glucose as glycogen in the liver. Glucose is an essential energy source for the body and is used as the primary source of energy when the body is in a state of hyperglycemia (high blood sugar).

Glycogen synthase is a protein that is expressed in many different tissues throughout the body, including the liver, pancreas, and muscle. It is a key enzyme in the metabolism of glucose and is involved in the biosynthesis of glycogen, which is the primary source of glucose in the body. The biosynthesis of glycogen is a critical process for maintaining the stability of blood glucose levels and is essential for maintaining the health and function of the body.

Glycogen synthase is a protein that is composed of multiple subunits that are encoded by the gene GSS. The subunits of Glycogen synthase include a catalytic subunit, which is responsible for catalyzing the final step of the biosynthesis pathway, and a regulatory subunit, which is responsible for regulating the activity of the enzyme. The catalytic subunit of Glycogen synthase is the active site of the enzyme and is the region of the protein that is responsible for catalyzing the final step of the biosynthesis pathway.

The catalytic subunit of Glycogen synthase is a hereditary protein that is encoded by the gene GSS. The catalytic subunit of Glycogen synthase is composed of a single polypeptide chain that is approximately 30 amino acids in length. The catalytic subunit of Glycogen synthase is responsible for catalyzing the final step of the biosynthesis pathway by catalyzing the addition of the final two amino acids to the 尾-glucan molecule that makes up the glycogen.

The regulatory subunit of Glycogen synthase is also a hereditary protein that is encoded by the gene GSS. The regulatory subunit of Glycogen synthase is responsible for regulating the activity of the enzyme by binding to the active site of the catalytic subunit and affecting the conformation of the enzyme. The regulatory subunit of Glycogen synthase is involved in the regulation of the activity of the enzyme by affecting the level of the catalytic subunit and the stability of the enzyme.

Glycogen synthase is a protein that is involved in the biosynthesis of glycogen, which is the primary source of glucose in the body. The biosynthesis of glycogen is a critical process for maintaining the stability of blood glucose levels and is essential for maintaining the health and function of the body. Glycogen synthase is an enzyme that is involved in this process and is a potential drug target or biomarker.

Glycogen synthase is a protein that is expressed in many different tissues throughout the body. It is a key enzyme in the metabolism of glucose and is involved in the biosynthesis of glycogen, which is the primary source of glucose in the body. The catalytic subunit of Glycogen synthase is responsible for catalyzing the final step of the biosynthesis pathway, while the regulatory subunit of Glycogen synthase is responsible for regulating the activity of the enzyme. Glycogen synthase is a potential drug target or biomarker that could be targeted by small molecules or other therapeutic agents to treat a variety of diseases.

Protein Name: Glycogen Synthase (nonspecified Subtype)

The "Glycogen synthase Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Glycogen synthase comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets